American Journal of Nephrology · 2004 · 81 citations · 21 references
Life SciencesImmunologyMolecular BiologyCell SignalingInflammationSignal TransductionCytokine BiologyCytokine Receptor SignalingCytokine RegulationCytokine SignalingInflammatory MediatorsInflammatory SignalingAcute-phase MediatorsCytokine-mediated Vascular ResponsesDirect EffectsInterleukin-6 Mediated RegulationJak InhibitorsJak-stat Signaling PathwayJanus Kinase-stat Signaling ActivationVascular Smooth Muscle Regulation
BACKGROUND/AIMS: IL-6, an inducer of the acute-phase response, is linked with the development of vascular disease and atherosclerosis. One mechanism likely involves direct effects of IL-6 on vascular smooth muscle cells (VSMC), for IL-6 can induce VSMC proliferation and the release of monocyte chemoattractant protein-1 (MCP-1). We hypothesized that this stimulation occurs via the JAK (janus-activated kinase)/STAT (signal and transducers and activators of transcription) signaling pathway. METHODS: Rat VSMC were stimulated with IL-6 in the presence or absence of a JAK 2 inhibitor, and the activation of STAT 3 (by Western), MCP-1 (by ELISA) and DNA synthesis (by (3)H-thymidine incorporation) was determined. RESULTS: IL-6 rapidly induced phosphorylation of STAT 3 in a dose- and time-dependent manner with a peak expression at 30 min. IL-6 also stimulated MCP-1 protein production and DNA synthesis dose dependently. 50 microM of AG490, a specific JAK 2 inhibitor, partially inhibited STAT 3 activation and MCP-1 production, with near complete inhibition of DNA synthesis. CONCLUSION: The JAK/STAT pathway partially mediates IL-6-induced MCP-1 production and DNA synthesis in rat VSMC. These studies implicate a role of the JAK/STAT pathway in the development of vascular disease and atherosclerosis.
21
Elevated Levels of Interleukin-6 in Unstable Angina
Luigi M. Biasucci, Alessandra Vitelli, Giovanna Liuzzo et al. · Circulation · 1996 · 737 citations